Fibroblast activation protein (FAP), a membrane-bound protease, targeted by CAR-T cells, effectively enhances the killing of tumor cells in vitro and is considered a suitable target for CAR-T cell therapy against immune-suppressive TME components (106, 144). Here, FAP is linked to neoplasm.